V
40
4
AAP
26
-7
EQR
25
5
DVA
47
-4
XEL
79
5
ALL
54
6
INTC
61
5
QRVO
59
6
PSA
35
15
MS
61
2
NAVI
40
2
PG
20
-2
L
67
3
ACN
22
6
PEP
56
3
LOW
24
-4
NFLX
58
4
TAP
35
4
BLK
49
3
KMX
42
2
V
40
4
AAP
26
-7
EQR
25
5
DVA
47
-4
XEL
79
5
ALL
54
6
INTC
61
5
QRVO
59
6
PSA
35
15
MS
61
2
NAVI
40
2
PG
20
-2
L
67
3
ACN
22
6
PEP
56
3
LOW
24
-4
NFLX
58
4
TAP
35
4
BLK
49
3
KMX
42
2
Financhill
Back

Bahl & Gaynor Small/Mid Cap Income Growth ETF Vs. Apogee Therapeutics, Inc. Industry Stock Comparison

Sell
43

SMIG
Bahl & Gaynor Small/Mid Cap Income Growth ETF

Last Price:
$29.39
Seasonality Move:
-1.47%
Sell
44

APGE
Apogee Therapeutics, Inc.

Last Price:
$84.40
Seasonality Move:
-11.77%
Sell
43
Bahl & Gaynor Small/Mid Cap Income Growth ETF (SMIG) is a Sell

Is Bahl & Gaynor Small/Mid Cap Income Growth ETF a Buy, Sell or Hold?

  • The current Bahl & Gaynor Small/Mid Cap Income Growth ETF [SMIG] share price is $29.38. The Score for SMIG is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • SMIG is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
44
Apogee Therapeutics, Inc. (APGE) is a Sell

Is Apogee Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Apogee Therapeutics, Inc. [APGE] share price is $84.34. The Score for APGE is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • APGE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SMIG Stock Price Chart

What is Bahl & Gaynor Small/Mid Cap Income Growth ETF's stock price today?

  • The Bahl & Gaynor Small/Mid Cap Income Growth ETF share price today is $29.38
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SMIG is experiencing slight buying pressure.

APGE Stock Price Chart

What is Apogee Therapeutics, Inc.'s stock price today?

  • The Apogee Therapeutics, Inc. share price today is $84.34
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and APGE is experiencing buying pressure, which is a positive indicator for future bullish movement.

SMIG Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.35 Sell
Relative Strength Index (14 RSI): 42.29 Sell
Chaikin Money Flow: 51740 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (29.11 - 30.59) Sell
Bollinger Bands (100): (28.56 - 30.66) Sell

APGE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.18 Buy
Relative Strength Index (14 RSI): 64.96 Buy
Chaikin Money Flow: 432550 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (69.1 - 79.44) Buy
Bollinger Bands (100): (66.23 - 78.47) Buy

SMIG Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 29.26 Buy
20-day SMA: 29.53 Sell
50-day SMA: 30.36 Sell
200-day SMA: 29.45 Sell
8-day EMA: 29.31 Buy
20-day EMA: 29.61 Sell
50-day EMA: 29.92 Sell
200-day EMA: 29.49 Sell

APGE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 79.91 Buy
20-day SMA: 75.21 Buy
50-day SMA: 71.36 Buy
200-day SMA: 57.28 Buy
8-day EMA: 80.37 Buy
20-day EMA: 76.41 Buy
50-day EMA: 73.33 Buy
200-day EMA: 61.58 Buy

Bahl & Gaynor Small/Mid Cap Income Growth ETF Earnings Growth & SMIG Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Apogee Therapeutics, Inc. Earnings Growth & APGE Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.21 per share, a decrease this year of $0.63 per share, and a decrease next year of $0.62 per share.

Bahl & Gaynor Small/Mid Cap Income Growth ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apogee Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):